| Date Filed | Type | Description |
| 08/22/2023 |
4
| Gutierrez-Ramos Jose-Carlos (SVP, Chief Science Officer) has filed a Form 4 on DANAHER CORP /DE/|
Txns:
| Sold 590 shares
@ $250.54, valued at
$147.8k
|
|
| 08/21/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 06/12/2023 |
4
| Gutierrez-Ramos Jose-Carlos (Director) has filed a Form 4 on Evelo Biosciences, Inc.|
Txns:
| Granted 20,000 options to buy
@ $0.11, valued at
$2.2k
|
|
| 05/02/2023 |
4
| Gutierrez-Ramos Jose-Carlos (SVP, Chief Science Officer) has filed a Form 4 on DANAHER CORP /DE/|
Txns:
| Sold 500 shares
@ $242.1928, valued at
$121.1k
|
|
| 05/01/2023 |
4
| Gutierrez-Ramos Jose-Carlos (SVP, Chief Science Officer) has filed a Form 4 on DANAHER CORP /DE/|
Txns:
| Granted 1 options to buy
@ $236.91, valued at
$171.3 |
|
| 05/01/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 02/28/2023 |
4
| Gutierrez-Ramos Jose-Carlos (SVP, Chief Science Officer) has filed a Form 4 on DANAHER CORP /DE/|
Txns:
| Paid exercise price by delivering 481 shares
@ $249.12, valued at
$119.8k
Granted 4,015 shares
@ $0
Granted 16,274 options to buy
@ $249.12, valued at
$4.1M
Granted 10,849 options to buy
@ $249.12, valued at
$2.7M
|
|
| 02/02/2023 |
5
| Gutierrez-Ramos Jose-Carlos (SVP, Chief Science Officer) has filed a Form 5 on DANAHER CORP /DE/ |
| 02/02/2023 |
4
| Gutierrez-Ramos Jose-Carlos (SVP, Chief Science Officer) has filed a Form 4 on DANAHER CORP /DE/|
Txns:
| Granted 461 options to buy
@ $267.5, valued at
$123.3k
|
|
| 01/30/2023 |
4
| Gutierrez-Ramos Jose-Carlos (SVP, Chief Science Officer) has filed a Form 4 on DANAHER CORP /DE/|
Txns:
| Granted options to buy
@ $265.98, valued at
$43.4 |
|
| 01/05/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/31/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/02/2022 |
4
| Gutierrez-Ramos Jose-Carlos (SVP, Chief Science Officer) has filed a Form 4 on DANAHER CORP /DE/|
Txns:
| Granted options to buy
@ $291.47, valued at
$43.1 |
|
| 04/05/2022 |
4
| Gutierrez-Ramos Jose-Carlos (Director) has filed a Form 4 on Evelo Biosciences, Inc.|
Txns:
| Granted 40,000 options to buy
@ $3.36, valued at
$134.4k
|
|
| 04/05/2022 |
3
| Gutierrez-Ramos Jose-Carlos (Director) has filed a Form 3 on Evelo Biosciences, Inc. |
| 02/28/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/02/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/05/2022 |
4
| Gutierrez-Ramos Jose-Carlos (Director) has filed a Form 4 on BICYCLE THERAPEUTICS plc|
Txns:
| Granted 5,000 shares
@ $0
Granted 10,000 options to buy
@ $60.87, valued at
$608.7k
|
|
| 03/19/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/19/2021 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 02/26/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/21/2020 |
3
| Gutierrez-Ramos Jose-Carlos (SVP, Chief Scientific Officer) has filed a Form 3 on DANAHER CORP /DE/ |
| 10/01/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/20/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/24/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/23/2020 |
4
| Gutierrez-Ramos Jose-Carlos (Director) has filed a Form 4 on MOMENTA PHARMACEUTICALS INC|
Txns:
| Sold 5,734 shares
@ $29.1, valued at
$166.9k
Sold 4,356 shares
@ $29.09, valued at
$126.7k
|
|
| 06/21/2019 |
4
| Gutierrez-Ramos Jose-Carlos (Director) has filed a Form 4 on MOMENTA PHARMACEUTICALS INC|
Txns:
| Granted 25,000 options to buy
@ $12.64, valued at
$316k
Exercised 4,356 restricted stock units
@ $0 |
|
| 06/14/2019 |
4
| Gutierrez-Ramos Jose-Carlos (Director) has filed a Form 4 on Evelo Biosciences, Inc.|
Txns:
| Granted 31,380 options to buy
@ $7.07, valued at
$221.9k
|
|
| 06/14/2019 |
3
| Gutierrez-Ramos Jose-Carlos (Director) has filed a Form 3 on Evelo Biosciences, Inc. |
| 06/22/2018 |
4
| Gutierrez-Ramos Jose-Carlos (Director) has filed a Form 4 on MOMENTA PHARMACEUTICALS INC|
Txns:
| Granted 8,855 options to buy
@ $22.3, valued at
$197.5k
Granted 4,356 restricted stock units
@ $0
Exercised 5,734 restricted stock units
@ $0 |
|
| 03/16/2018 |
4
| Gutierrez-Ramos Jose-Carlos (See Remarks) has filed a Form 4 on SYNLOGIC, INC.|
Txns:
| Granted 120,540 options to buy
@ $9.95, valued at
$1.2M
|
|
| 02/13/2018 |
5
| Gutierrez-Ramos Jose-Carlos (See Remarks) has filed a Form 5 on SYNLOGIC, INC. |
| 08/30/2017 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 06/22/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
|